Solanezumab has recently been identified as a potential treatment option for Alzheimer’s disease.
Which one of the following statements is CORRECT?

Question

Solanezumab has recently been identified as a potential treatment option for Alzheimer’s disease.  
 Which one of the following statements is CORRECT?

Accepted Answer

Solanezumab is a monoclonal antibody that binds specifically to soluble amyloid β and promotes amyloid β clearance from the brain through the blood.

Answer

Solanezumab is an active form of immunisation.

Answer

Its use in a clinical trial was stopped because of aseptic meningoencephalitis.

Answer

It is a new vaccine that selectively targets B cell epitopes.

Crowdly

Solanezumab has recently been identified as a potential treatment option for Alz...

Хочете миттєвий доступ до всіх перевірених відповідей на learning.monash.edu?